Introduction
The mammalian intestinal epithelium is arranged in villi (small bowel) or flat cuffs (colon) associated with mucosal invaginations known as the crypts of Lieberkühn. Each crypt houses a monoclonal population of stem and progenitor cells that proliferate near its base; differentiated progeny reside higher along small intestinal villi (Cheng and Leblond, 1974; Potten, 1998; Simon and Gordon, 1995) . Differentiated epithelial cells arise in intimate contact with the underlying mesenchyme, and intestinal organogenesis relies on epithelialmesenchymal interactions (Haffen et al., 1987; Kedinger et al., 1998; Rubin et al., 1992) . Directed investigation of selected signaling pathways has uncovered roles for hedgehog, TGF-β family and Wnt proteins in this process (Batlle et al., 2002; Korinek et al., 1998; Ramalho-Santos et al., 2000; Roberts et al., 1995) , whereas mouse gene knockouts have implicated other regulators, often serendipitously (Hentsch et al., 1996; Kaestner et al., 1997; Karlsson et al., 2000; Katz et al., 2002; Yang et al., 2001) . However, the mediators of many essential cellular interactions remain unknown and understanding of intestine organogenesis is incomplete.
The fetal mouse gut endoderm, which appears as a
The vertebrate intestine is a model for investigating inductive cellular interactions and the roles of epithelial stem cells in tissue regeneration, and for understanding parallels between development and cancer. We have used serial analysis of gene expression to measure transcript levels across stages in mouse intestine development. The data (http://genome.dfci.harvard.edu/GutSAGE) identify novel differentiation products, potential effectors of epithelial-mesenchymal interactions, and candidate markers and regulators of intestinal epithelium. Transcripts that decline significantly during intestine development frequently are absent from the adult gut. We show that a significant proportion of such genes may be reactivated in human colon cancers. As an example, hepatoma-derived growth factor (HDGF) mRNA is expressed prominently in early gut tissue, with substantially reduced levels after villous epithelial differentiation. HDGF expression is dramatically increased in human colorectal cancers, especially in tumors proficient in DNA mismatch repair, and thus represents a novel marker for a distinctive tumor subtype. HDGF overexpression in fetal intestine explants inhibits maturation, suggesting a role in epithelial differentiation. To investigate the molecular basis for HDGF functions, we isolated components of a nuclear HDGF complex, including heterogeneous nuclear ribonucleoproteins implicated in processing RNA. These genes are regulated in tandem with HDGF during intestine development and one factor, TLS/Fus, is commonly overexpressed in colon cancers. Tumor expression of fetal genes may underlie similarities between developing and malignant tissues, such as selfrenewal, invasion and angiogenesis. Our findings also advance understanding of HDGF functions and implicate this developmentally regulated gene in RNA metabolic pathways that may influence malignant behaviors in colorectal cancer.
pseudostratified epithelium between embryonic days (E) 12 and 13, undergoes a pivotal cellular transition over the ensuing 2 days to form the first rudimentary intestinal villi (Fig. 1A) and to initiate expression of lineage-specific genes (Maunoury et al., 1992; Simon et al., 1993) . We reasoned that accurate transcriptional profiles over this developmental interval could provide fundamental information about underlying mechanisms, and characterized intestinal gene expression using serial analysis of gene expression (SAGE) (Velculescu et al., 1995) . Coupled with localization of gene products, the resulting mRNA profiles (http://genome.dfci.harvard.edu/ GutSAGE) identify candidate regulators of cell interactions and mucosal differentiation. We also applied this resource to address longstanding questions about reactivation of fetal genes in cancer.
Cancer cells display immature features and dysregulated gene expression, with attenuation of tumor suppressors and aberrant expression of genes that are inactive in normal adult tissue. Some proteins expressed exclusively in tumors and in developing embryos, such as carcinoembryonic antigen, are onco-fetal markers that assist in clinical cancer management (Carr et al., 1997; Uriel, 1975) . Besides some recent advances (Kho et al., 2004) , the extent to which tumor cells recapitulate embryonic gene expression and the significance of this phenomenon are unknown. We find that transcripts whose abundance declines significantly during gut development frequently are absent from the adult intestine, and many such genes are reactivated in human tumors of the same fetal origin. Among developmentally regulated genes, we report here frequent overexpression in colorectal tumors of the hepatomaderived growth factor (Hdgf) and the results of studies that investigate its cellular and differentiation functions.
HDGF was first isolated from conditioned fibroblast media as a factor that stimulated proliferation of heterologous cultured cells (Nakamura et al., 1994; Oliver and Al-Awqati, 1998) . Although it is hence regarded as a growth factor, the amino acid sequence lacks a signal peptide but includes a region homologous to the high-mobility group (HMG) box of nuclear proteins (Nakamura et al., 1994 ) and a nuclear localization signal that is essential for its activities (Everett et al., 2001; Kishima et al., 2002) . Two groups have characterized a related protein LEDGF (lens epithelium-derived growth factor) as a nuclear protein and apparent transcriptional regulator (Fatma et al., 2001) . To date, insight into HDGF functions derives largely from study of cell lines, and its physiological roles in development or cell differentiation are obscure. Prompted by our demonstration of its significant regulation in the developing intestine and frequent reexpression in DNA mismatch repair (MMR)-proficient colon cancers, we identified HDGF-associated nuclear proteins and investigated HDGF functions in gut epithelial differentiation.
Materials and methods
Serial analysis of gene expression Libraries were constructed as described (Velculescu et al., 1995) with RNA extracted from pooled fetal intestines, using NlaIII and BsmFI as the anchoring and tagging restriction enzymes, respectively. SAGE tags were extracted, filtered and tabulated using SAGE2000 software, and gene annotations were updated using the mouse gene version released on 18 August 2004. Statistical analysis was performed using Monte Carlo simulation, as described (Velculescu et al., 1995) . Listed values represent the probability (P-chance) that observed differences in SAGE tag frequency might result from chance alone. Because assignment of genes to SAGE tags can be equivocal, the analytic program assigns multiple genes to some tags and scores each assignment according to the degree of confidence: transcripts with well characterized cDNA clones receive the highest score, whereas assignments based exclusively on poorly characterized or EST clones receive low scores. Our database lists the highest scoring gene assignments; in the few cases where the top two or three possible assignments received similar scores, each of these possibilities is listed. We noted ~91% concordance between computational (highest score) and manual gene assignments for ~400 tested tags. Functional classification of genes was according to Gene Ontology Consortium criteria, and genes were clustered according to patterns of temporal variation using published methods .
RT-PCR
Pooled RNA samples, different from those used to construct SAGE libraries, were extracted with Trizol (Invitrogen), treated with RNasefree DNaseI (Ambion) and reverse transcribed with oligo-(dT) primer. First-strand cDNA was used as the template for PCR amplification in the presence of 0.01 mCi/ml [ 32 P] dCTP with T m of 62°C. Cycle numbers were adjusted to ensure linear amplification, and PCR products were resolved by non-denaturing polyacrylamide gel electrophoresis and detected by autoradiography. PCR primers are listed in Tables S2A,B in the supplementary material, unless reported previously (Tou et al., 2004) . Glyceraldehyde 3-phosphate dehydrogenase (GAPD), human β-amyloid and mouse hypoxanthine phosphoribosyl transferase (HPRT) mRNAs verified equal sample loading.
In situ hybridization RNA in situ hybridization was performed on 6-10 µm paraffin sections of paraformaldehyde-fixed whole embryos or isolated fetal or adult intestine, using digoxigenin-labeled (Roche) riboprobes. Rehydrated tissue sections were treated successively with 50 µg/ml proteinase K, 0.2 M HCl, 0.1 M triethanolamine in 0.25% acetic anhydride and 2ϫSSPE. Slides were incubated in hybridization buffer containing 50% formamide for 4 hours at 60°C, then hybridized overnight with the probe at 60°C, washed in 0.2ϫSSC at 60°C, blocked for 2 hours at room temperature with 10% goat serum and 2 mg/ml bovine serum albumin diluted in PBS containing 0.1% Triton-X100 (PBT), and incubated overnight at 4°C with alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche). After washing, slides were treated with 5 mM levamisole (Sigma), rinsed in alkaline buffer, treated with NBT/BCIP solution (Roche), postfixed in 4% paraformaldehyde, counterstained with Methyl Green, and examined by light microscopy. Images were captured on a CCD camera (QCapture) with Photoshop7.0 software (Adobe).
Immunostaining
Trp53 (DO-1, Santa Cruz), Ki67 (NovoCastra), HDGF (Everett et al., 2001) , hnRNPK (gift of K. Bomsztyk, University of Washington), TLS/Fus (gift of D. Goodman, Vollum Institute, Oregon) and other antibodies were used to stain 7 µm paraffin wax embedded sections of human colorectal tumors, mouse fetal intestine or cultured HeLa cells. Sections were rehydrated, fixed further in 4% paraformaldehyde in PBS, and treated successively with warm 0.01 M citrate (pH 6), 40% methanol in 0.3% hydrogen peroxide, and PBS containing 10% goat and 10% fetal bovine sera or 5% milk. Slides were incubated sequentially with antibodies diluted in PBS containing 5% goat serum, horseradish peroxidase-conjugated anti-mouse (Amersham Pharmacia) or anti-rabbit (Santa Cruz Biotechnology) IgG and diaminobenzidine peroxidase substrate (Vector Laboratories). Mounted sections were examined for image capture as described above. Cultured cells were fixed in 4% paraformaldehyde for 15 minutes, permeabilized in 0.1% NP-40 for 5 minutes, and blocked with 3% bovine serum albumin (BSA) in PBS containing 0.1% Triton (PBST). Antibody incubation was in PBST with 3% BSA and fluorophore-conjugated secondary antibody (Jackson ImmunoResarch Laboratories) incubation in PBST for 30 minutes. Cells were washed in PBST, mounted in aqueous medium containing DAPI, and confocal images were captured on the LSM510 imaging system (Zeiss).
Organ explant and cell culture
Intact mouse fetal intestines were dissected and cultured as described (Tou et al., 2004) , over filter disks in Fitton-Jackson-modified BGJb medium (Life Technologies) containing 0.1 mg/ml ascorbic acid. Explants were maintained in 5% CO 2 atmosphere, with medium changed every 2 days. pK7 plasmid DNA (2 mg/ml) encoding green fluorescent protein (GFP)-tagged full-length or truncated HDGF (Everett et al., 2001 ) was flushed into the gut lumen by capillary injection, followed by placement between platinum electrodes and delivery of three 10 ms pulses of 80 V each using a BTX830 squarewave electroporator (BTX, San Diego, CA), washing and culture.
HeLa cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 50 µg/ml streptomycin. Apoptosis was induced by treating the cells for 16 hours with 2 ng/ml human TNFα and 35 µM cycloheximide (Sigma). Necrosis was induced by treatment for 16 hours with ionomycin (Sigma) in serum-free DMEM. For permeabilization, cells was washed with ice-cold buffer containing 20 mM HEPES (pH 7.3), 110 mm K acetate, 5 mM Na acetate, 2 mM Mg acetate, 1 mM EGTA, 2 mM DTT and protease inhibitors, incubated on ice in the same buffer with 0.1% NP-40, washed twice with PBS and continued for immunostaining.
Isolation of HDGF-associated proteins
The detailed purification procedure has been described previously (Nakatani and Ogryzko, 2003) . Briefly, HeLa cells stably expressing Flag and HA epitope-tagged HDGF were propagated in suspension. Nuclear extracts were isolated from 12 L cultures and HDGF complexes were purified successively with anti-Flag and anti-HA antibodies (Sigma). Purified complexes were separated by 4-20% gradient SDS-PAGE and stained with silver stain. Individual protein bands were excised, digested with trypsin and analyzed by tandem mass spectrometry (Taplin Biological Mass Spectrometry Facility, Harvard Medical School). Tryptic peptides were matched to proteins by the Sequest database-searching program. For glycerol gradient sedimentation, concentrated HeLa or mouse E13.5 intestine nuclear extracts were loaded over 5 ml of a 10-40% glycerol gradient and centrifuged for 10 hours at 236,000 g (Beckman SW 55 Ti rotor). Individual 100 µl fractions were resolved by SDS-PAGE and analyzed by immunoblotting.
Results
SAGE analysis of mouse gut development SAGE sequence tags (14 bp) identify individual transcripts with high accuracy and the frequency of individual SAGE tags reliably reflects abundance of the corresponding mRNA in vivo. SAGE also reveals novel transcripts that may escape gene prediction or isolation (Chen et al., 2002; Moreno et al., 2001) , and the results are readily disseminated to assist hypothesisdriven investigation. We applied SAGE to identify transcriptional changes that accompany development of the mouse small intestine at post-coital days (E) 12, 13 and 15. Intestinal morphology between E12 and E13 is similar (Fig.  1A) , and their expression profiles may be enriched for transcripts that regulate the subsequent villous transformation.
We identified over 65,000 SAGE tags representing over 10,000 unique transcripts from each tested developmental stage. Analysis of the E15 data revealed nearly every tissue-enriched mRNA reported in the intestine (data not shown), indicating an adequate sequencing depth. Because there can be ambiguity in assigning transcripts to individual SAGE tags, we checked manually the annotation of transcripts corresponding to ~400 SAGE tags and found 91% concordance between the manual and highest-scoring computational assignments (see Materials and methods). The data thus provide good representation of the relative tissue abundance of currently annotated transcripts.
Thirty-eight out of 40 transcripts tested independently by reverse transcription (RT)-PCR showed expression changes concordant with the SAGE data (represented in Fig. 1B ), as did eight out of nine independent genes by northern analysis (represented in Fig. 1E ), attesting to the fidelity of SAGE results. As an example, Gli1 mRNA, a target and effector of hedgehog signaling (Marigo et al., 1996) , is significantly downregulated after E13 (Fig. 1B) , consistent with reported expression dynamics (Ramalho-Santos et al., 2000) and with prior evidence for obligate attenuation of hedgehog signaling in vertebrate gut differentiation (Zhang et al., 2000) . Similarly, the levels of Fabpi (Fabp2 -Mouse Genome Informatics), Fabpl (Fabp1 -Mouse Genome Informatics), Cdx2 and other mRNAs vary in agreement with published results (see Table  S1 in the supplementary material; and data not shown). Our complete dataset (http://genome.dfci.harvard.edu/GutSAGE), annotated with comprehensive functional and genetic information, thus provides a unique resource to outline the composition of molecular pathways active in mammalian intestine organogenesis.
Insights into gut development derived from SAGE expression profiles coupled with transcript localization
We record 703 significant (P<0.015) temporal changes in transcript abundance, revealing notable modulation of gene activity as the epithelium differentiates (http://genome.dfci.harvard.edu/GutSAGE). A representative amount of this analysis (see Table S1 in the supplementary material) outlines prominent transcriptional alterations that accompany the villous transition in intestine development. Expression of selected adult epithelial markers is known to occur by E15 (Maunoury et al., 1992; Simon et al., 1993) . Numerous transcripts associated with mucosal architecture (e.g. cadherin 17 and transgelin), metabolic or secretory functions (e.g. lipid-binding proteins and cryptdin peptides), and surface markers of cell maturation (e.g. galactose-binding lectins) are detected concomitantly. To capture changes occurring in all major cellular compartments, we prepared SAGE libraries from unfractionated tissue. Moreover, the intestinal long axis undergoes regional patterning during development, whereas our profiling considered the small bowel as a single organ and excluded the cecum and colon. Consequently, the expression data alone do not identify sites of gene expression within the developing gut. For genes of particular interest, this limitation is readily overcome by complementary approaches, including RNA in situ hybridization, to localize transcripts. Fig. 1C illustrates the value of these methods to map spatiotemporal patterns of fetal gene expression.
Transcripts that increase significantly at E15 are usually present at high levels in the adult organ (three examples shown in Fig. 2 , 'Increasing') and some of them can serve as molecular markers of tissue differentiation. Examples include the pyrin-CARD domain caspase-recruiting protein ASC and proline-rich acidic protein 1 (Prap1). The latter was originally described as a selective marker of the pregnant uterus (Kasik and Rice, 1997) and later found to be expressed at high levels in the adult small bowel (Bates et al., 2002) . Detailed examination of Prap1 mRNA expression confirms its activation after E13 in a regionally restricted manner that anticipates its distribution in the adult organ (Fig. 1D) . We have also shown Prap1 to be a useful in vitro marker of intestinal epithelial cytodifferentiation (Tou et al., 2004) .
The transition from a squamous into a columnar epithelium is associated with establishment of new intercellular junctions and cell polarity. Accordingly, the gene expression profiles reveal substantial changes in the concentrations of transcripts encoding structural or regulatory cytoskeletal proteins, including keratins 18 and 19, cadherins, a number of actinbinding factors and genes such as Lgl1, which determines cell polarity in other species and tissues (Klezovitch et al., 2004) . Our results further reveal temporal regulation of the components of several signaling pathways (Table 1) , including secreted factors that can bind extracellular matrix (ECM) and may function in short-range intercellular communication. Expression of these factors in the gut has not been revealed through other experimental approaches and they are attractive candidate mediators of tissue interactions in gut organogenesis. Examples include ECM-binding factors such as midkine; cell surface receptor-associated proteins such as Grb10 and the integrin-linked kinase; suppressors of cytokine signaling such as WSB-1; and several phosphatases. Consistent with possible functions in influencing tissue morphogenesis, many of these transcripts peak in expression at E12 or E13. One surprise is the abundant and regulated expression of the parathyroid hormone receptor gene Pthr1 (Fig. 1B, Table 1 ), which prompted us to examine fetal gut histology prior to the gestational lethality of Pthr1 -/-mouse embryos (Lanske et al., 1996) . Although this study failed to reveal gross defects in Pthr1 -/-intestines (data not shown), the expression dynamics could reflect a developmental role with compensated or subtle manifestations.
Among transcripts classified according to presumptive cellular functions, the E13 mouse intestine shows peak expression of a number of genes associated with protein folding or cellular stress responses, a finding verified by tissue northern analysis (Fig. 1E) . Expression of these genes is confined to the epithelial compartment (shown for Calr in Fig.  1E ). These observations raise the possibility that certain developmental transitions share molecular features with cellular stress; alternatively, the regulated expression of heatand stress-response genes may reflect metabolic or biosynthetic functions associated with emergence of an absorptive and secretory epithelium. Transcriptional profiles, coupled with mRNA localization studies, can thus lead to specific hypotheses about the functions of groups of coexpressed genes. Here, we focus on the significance of specific trends in gene expression.
Significance of transcripts that decline in abundance with progressive epithelial differentiation
Genes with reduced expression past E13 potentially serve functions that are restricted to the period of organogenesis. Indeed, the proportion of the genome that is dedicated to developmental functions is unclear. We assessed expression of 32 transcripts, selected arbitrarily from a total of 254 genes that showed higher SAGE representation at E12 or E13 than at E15. Seven of these mRNAs were undetectable past E15 (Fig. 2 , 'Decreasing', four examples shown), whereas 25 transcripts could be detected again at E17 ('Dynamic', seven examples). Half of the Dynamic, and all the Decreasing, transcripts are weakly or not detected in any segment of the adult intestine with a sensitive RT-PCR assay (Fig. 2) . Because analysis of RNA isolated from the whole organ may underestimate expression that is confined to minor cell populations, we confirmed absence of most of these transcripts in the adult mouse gut by in situ hybridization (data not shown). Transient expression of many genes during organogenesis suggests that a substantial fraction of mammalian genes may serve dedicated functions in development, although some mRNAs in this class (e.g. Pthr1) may have separate roles in other sites (Urena et al., 1993) . Moreover, groups of fetally expressed genes may be subject to common molecular mechanisms of gene silencing concomitant with tissue differentiation.
Silencing of genes during normal development may be (Carr et al., 1997; Uriel, 1975) ; however, the extent to which tumor cells recapitulate embryonic gene expression and the significance of this phenomenon are unknown. We therefore (Bates et al., 2002; Potten, 1998) ; colon cancer is the second leading cause of cancer death in many developed nations, whereas primary tumors of the small bowel are rare (http://seer.cancer.gov). First, we identified the known or presumptive orthologous human gene and designed suitable primers for RT-PCR; 27 primer pairs for the corresponding human genes amplified the predicted fragment reliably. Second, we rigorously established two independent standards (GAPD and β-amyloid) to ensure equal loading of RNA from each matched pair of tumor and normal tissue (Fig. 3A,B) and we amplified Tgfbi, a TGFβ-inducible gene whose expression is known to be elevated in colon cancers (Zhang et al., 1997) , as a positive control. Like Tgfbi, seven out of the 27 reaction sets showed overexpression of the corresponding gene in at least two out of the seven tumors (Fig. 3B) , a result we quantified by densitometry (e.g. Fig. 3C ). The remaining transcripts show variable levels in normal and tumor samples, without consistent patterns (e.g. Calm3). Histological inspection of the tumors excluded a higher epithelial:stromal ratio as a trivial explanation for elevated levels of epithelial transcripts (data not shown), and for those markers we could test (e.g. Trp53 and Hdgf; Fig. 3D and Fig. 4D ), the protein is present in tumor cells but not in the stroma. The tumors show heterogeneity in expression of fetal genes, as expected, although two transcripts, Tls/Fus and Trp53, are increased in nearly every tumor. Trp53 is commonly mutated in cancers and elevated protein levels are believed to result from post-translational stabilization (Kubbutat et al., 1997) ; our study reveals increased mRNA levels of this developmentally regulated gene. Tls/Fus [also called pigpen in the mouse (Alliegro and Alliegro, 1996) ] is a recurring target of chromosomal translocation in human myxoid liposarcoma (Rabbitts et al., 1993) , where its pathogenic mechanisms are unclear.
Because our results reveal that many developmentally downregulated genes are re-expressed in tumors, understanding their respective cellular roles can inform both developmental and cancer biology. Here, we focus on one such product. Hepatoma-derived growth factor (HDGF) was isolated from conditioned cell culture media as a protein that weakly stimulated proliferation of heterologous cells (Nakamura et al., 1994) . However, HDGF harbors a nuclear localization signal (NLS) that is essential for its mitogenic activity (Everett et al., 2001; Kishima et al., 2002) . Conclusions about its proposed functions (Everett et al., 2000; Oliver and Al-Awqati, 1998; Zhou et al., 2004) rely mainly on studies in cultured cell lines; the physiological roles and molecular mechanisms are poorly understood.
HDGF expression in mammalian fetal gut development and colorectal cancer HDGF mRNA is downregulated concomitantly with transition of the gut endoderm into a villous epithelium and there is a corresponding, albeit delayed, decline in protein levels (Fig.  4A) . In the fetal gut, HDGF mRNA and protein localize in the developing mucosa and are excluded from the mesenchyme (Fig. 4B) ; HDGF protein is restricted to cell nuclei. In the adult intestine, weak residual HDGF expression is confined to nuclei in the lower half of the villous projections (Fig. 4C) , the site of temporary residence of undifferentiated epithelial cells. HDGF expression thus correlates with undifferentiated states in the developing and adult gut mucosa; there is no variation along the rostrocaudal axis of the digestive tract (data not shown).
In Fig. 3B , we show elevated HDGF mRNA in 2 of 7 human colon cancers. HDGF protein was overexpressed in 14 of 28 colorectal cancers we tested independently by immunohistochemistry (Fig. 4D) . Again, HDGF was present only in nuclei and overexpressed in the tumor compartment; cells at the invasive front, particularly isolated invasive foci and large cells with undifferentiated morphology, were often the most strongly stained (Fig. 4E ). This finding may be pertinent to the role of HDGF-containing complexes discussed below, and staining throughout the cancerous tissue argues against HDGF simply marking rapidly dividing cells. Colon cancers with deficient or intact DNA mismatch repair (MMR) express distinctive genetic, biological, and prognostic features but there is limited understanding about the molecular basis for these differences (Peltomaki, 2003) . Notably, HDGF was overexpressed in 11 out of the 16 tumors proficient for MMR, compared with three out of 12 MMRdeficient colon cancers ( Fig. 4F; P=0 .027 by the Fisher exact test). Thus, although HDGF is expressed weakly in normal adult gut mucosa, our findings reveal oncofetal properties and especially elevated expression in MMR-proficient colon tumors.
Development 132 (2) Research article Isolation and characterization of an HDGFcontaining nuclear protein complex HDGF has few sequence motifs that suggest possible cellular functions, except for partial homology with a subfamily of high-mobility group (HMG)-box proteins exemplified by HMGB1. The latter is also a nuclear protein that may be found in culture media, owing to its weak association with chromatin, which is disrupted in necrotic cells but enhanced when cells die by apoptosis (Scaffidi et al., 2002) . Indeed, as noted for HMGB1, native HGDF could be extracted from HeLa cell nuclei within 1 minute of mild NP-40 detergent treatment and completely within 5 minutes, whereas the chromatinassociated histone 2Az protein resisted such extraction (Fig.  5A) . In HeLa cells treated with ionomycin to induce necrosis, HDGF was lost from the cell nucleus, whereas after treatment with tumor necrosis factor α and cycloheximide, which induces apoptosis, HDFG remained in the nucleus (data not shown). These findings affirm nuclear expression of HDGF and might explain its appearance in conditioned cell media.
To better characterize HDGF function, we sought to isolate associated proteins with established cellular roles. We expressed double epitope-tagged HDGF by retroviral infection in HeLa cells, followed by immunoprecipitation from nuclear extracts using antibodies against the two synthetic epitopes (Nakatani and Ogryzko, 2003) . We identified several HDGFassociated proteins using mass spectrometric analysis and computer-assisted sequence searching. In two experiments ( Fig. 5B ; data not shown) we identified tryptic peptides that cover nearly 22% of the amino acid sequence of two novel and highly conserved proteins with predicted molecular mass of 80 kDa and 57 kDa (see Fig. S1 in the supplementary material). We also recovered three peptides each corresponding to heterogeneous nuclear ribonucleoproteins (hnRNPs) K and I, and the sarcoma oncoprotein TLS/Fus. hnRNPI has been shown independently to interact with each of the other proteins (Kim et al., 2000; Meissner et al., 2003) , and all three factors have well-characterized RNA-binding motifs; like HDGF, TLS/Fus mRNA is commonly increased in colorectal tumors (Fig. 3B) . These factors have not been isolated previously in HeLa cell co-precipitation with diverse protein baits.
Available antibodies against the putative HDGF-associated proteins lack immunoprecipitating activity, which precludes independent assessment of protein interactions. Instead, we Fig. 5 . HDGF properties and associations revealed through sequence similarities and isolation of a nuclear multi-protein complex. (A) Rapid release of nuclear HDGF but not histone 2Az protein following treatment of cultured HeLa cells with low concentrations of NP-40 detergent. This behavior parallels that of the related protein HMGB1 (Scaffidi et al., 2002) and may explain why HDGF previously was found intact in conditioned culture media. (B) Silverstained gel of HDGF immunoprecipitates from mock-transfected or epitope-tagged HDGF-overexpressing HeLa cells resolved by SDS-PAGE. The marked specific bands were extracted and identified by mass spectrometric analysis to contain the indicated proteins: two novel factors (Fig. S1) , hnRNPs K and I, and TLS/Fus, also known as mouse pigpen. (C) Immunoblot analysis of HeLa cell (top) and E13 mouse intestine (bottom) nuclear fractions resolved over a glycerol gradient and probed for the presence of HDGF, hnRNPK and TLS/Fus proteins. Resolution of protein complexes is similar in the two cell sources and indicates that a significant proportion of nuclear HDGF may be complexed with hnRNPK (red) and TLS/Fus (green), which in turn may associate independently with each other and with other factors in bulkier protein complexes. resolved nuclear extracts from HeLa cells and from E13 mouse intestine by glycerol gradient sedimentation. Specific antibodies against hnRNPK and TLS/Fus (hnRNPI antibody is not readily available) revealed partial co-sedimentation with HDGF, mainly in fractions 6-9 (Fig. 5C ). These results support the idea that nuclear HDGF associates, probably substoichiometrically, with these factors. Immunostaining for HDGF, TLS/Fus and hnRNPK confirmed diffuse nuclear localization of each within innumerable discrete foci (Fig. 5D) , although the subnuclear resolution is insufficient to verify colocalization of these abundant proteins. However, expression dynamics for the HDGF-associated proteins provide independent support for their participation in a common developmental pathway: mRNA and protein levels for both hnRNPK and TLS/Fus parallel that of HDGF in the fetal mouse gut (Fig. 5E) . The three HDGF-associated factors we studied are RNA-binding proteins. Our observations thus combine to place previously obscure HDGF mechanisms within a RNA metabolic pathway that is developmentally controlled and pertinent to cancer. Although the two novel HDGF-associated proteins (Fig. S1 ) lack discernible functional motifs, their identification also should enable further study of HDFG function.
Differentiation and cellular functions of HDGF
The strong correlation between HDGF expression and undifferentiated epithelial states (Fig. 4) led us to hypothesize that HDGF regulates mucosal cell differentiation negatively. We reasoned that if declining HDGF levels during gut development enable expression of maturation-associated genes, then forced HDGF expression may prevent or delay their activation. We introduced DNA by luminal injection and electroporation in intestines explanted from E14 mouse fetuses, when endogenous mRNA levels are dropping and prior to native expression of differentiation genes (Tou et al., 2004) . Epithelial expression of GFP-tagged HDGF fusion protein (Fig. 6A,B ) reduced mRNA levels of several intestine-specific differentiation markers: Apo1a, liver (Fabpl)-and intestine (Fabpi)-specific fatty acid-binding proteins, metallothionein 2 (Mt2), and Prap1 (Fig. 6C) . Villin RNA levels were unchanged, which implies that HDGF influences differentiation genes selectively, and expression of the inhibited markers recovered partially after additional culture, indicating that HDGF overexpression did not compromise explant viability. An inactive HDGF form lacking the NLS (Everett et al., 2001 ) did not affect differentiation-related mRNAs (Fig. 6C) ; levels of the intact and mutant proteins were comparable (Fig. 6B) . We have previously shown good correlation between molecular and histological maturation in fetal gut explants (Tou et al., 2004) . However, the conditions for DNA electroporation affect tissue morphology adversely and preclude evaluation of HDGF effects on epithelial cytodifferentiation.
The logical conclusion from these experiments, that high HDGF levels retard epithelial cell differentiation, ideally should be complemented by depletion of early HDGF expression. Although we could apply HDFG-specific short hairpin (sh) shRNAs to reduce transcript levels in cultured cells and organ explants, the protein resisted our depletion efforts (data not shown). Moreover, proteins related to HDGF (Dietz et al., 2002 ) might substitute for the loss of a single family member. Nevertheless, the overexpression studies indicate that excessive HDGF in the fetal intestine impairs expression of gut epithelial differentiation markers. Forced expression of TLS/Fus or hnRNPK did not abrogate or delay fetal gut epithelial differentiation, which suggests that HDGF may be a limiting factor.
Discussion
Insight into how individual genes influence development and differentiation derives largely from genetic and developmental studies. Broader understanding is often constrained by difficulties in tracking the many pathways that act simultaneously in organogenesis. Expression profiling can map active pathways and uncover processes not previously known to participate in development. The goals of expression profiling in developing organs include: (1) recording a reliable and searchable dataset that is validated and annotated with relevant and current gene information; (2) defining the repertoire of genes whose expression is modulated in space and time; (3) discovering novel molecular markers for distinct developmental stages; and (4) generating hypotheses about the functions of co-expressed genes. Here, we report the creation and use of a SAGE resource to advance these goals.
Development 132 (2)
Research article Experimental tests reproduce sample results from our analysis with more than 90% accuracy. Building on the quantitative aspects of SAGE, our web resource (http://genome.dfci.harvard.edu/GutSAGE) provides primary data on numbers of sequence tags and enumerates the statistical significance of differences measured across developmental stages. A versatile search function permits users to parse genes according to expression or functional criteria, with immediate access to the primary data. Tag and gene annotations are continually updated, as each SAGE entry is linked to three public resources: LocusLink, GeneOntology and SAGEmap; LocusLink will soon be replaced by its versatile successor Entrez Gene (http://www.ncbi.nlm.nih.gov/entrez/query/static/ help/genehelp.html). These features assure the currency of the data and will enable investigators to apply a developmental dataset to address many outstanding problems. In particular, the basis for important interactions between epithelial and mesenchymal cells may be revealed through signaling components that vary over the E12-E15 interval. Although the data presented in Table 1 do not imply a vital role for every listed product, they represent an enriched gene set for targeted investigation. Such studies could be facilitated by localizing gene expression using in situ hybridization and an array of stage-specific molecular markers identified in this study. These advances enhance the collective ability to address issues such as the relationship between fetal and adult mucosal stem cells and how or why certain classes of genes, such as the stressresponse group, are co-regulated during intestinal differentiation.
Genetic pathways that initiate intestinal tumors are well characterized (Batlle et al., 2002; Kinzler and Vogelstein, 1996) , whereas most alterations that accompany disease progression (Stoler et al., 1999) are not. Yet, it is the latter changes that probably underlie especially ominous features of colonic and other epithelial tumors, including tissue invasion, viability at distant sites and drug resistance. Each of these features is strongly correlated with the degree of tumor cell differentiation (Deans et al., 1994) , but the basis for this correlation is unknown. Although it is commonly assumed that poor differentiation of tumor cells reflects reversion to a primitive state, the definition of such states is vague. By contrast, in some leukemias and lymphomas, where relationships between tumor cells and steps in normal development or cell differentiation are defined precisely, the resulting insights guide both understanding and treatment of the disease (Tenen, 2003) . We have therefore begun to ask to what extent a common carcinoma might recapitulate the gene expression program associated with its developmental origins. Current cancer treatments, even when directed against molecular carcinogenic mechanisms, frequently are confounded by toxicities that limit the dose or discourage drug development. Such toxicity typically reflects expression of the drug target in non-tumor tissues. Oncofetal proteins that are essential for malignant behaviors thus represent attractive targets for cancer treatment because their absence or reduced levels in normal adult tissues may confer especially wide therapeutic windows. An approach to identify oncofetal proteins could thus find useful therapeutic applications.
Our findings implicate the oncofetal protein HDGF in regulation of normal and pathologic gut mucosal differentiation. In the mammalian gut, HDGF localizes in epithelial cells, peak expression coincides with the developmental villous transition and the protein is overexpressed in human colorectal cancers, especially those with intact DNA mismatch repair. HDGF is a nuclear protein rather than a classical, secreted growth factor and forced expression in the fetal mouse intestine retards epithelial development. HDGF shares discernible sequence similarity and cellular properties with the ubiquitous and abundant nuclear protein HMGB1 (Nakamura et al., 1994) , which may regulate gene transcription but also has differentiation and pathological roles when released from necrotic cells (Melloni et al., 1995; Muller et al., 2001; Scaffidi et al., 2002) . Presumably, both HDGF and HMGB1 are released passively from necrotic cells following lysis. More important from a mechanistic standpoint is our isolation of nuclear complexes wherein HDGF associates with well-characterized RNAbinding proteins.
Not only does HDGF associate with two hnRNPs and TLS/Fus but the four mRNAs are regulated in tandem in intestine organogenesis and both HDGF and TLS/Fus are commonly overexpressed in human colon cancers. TLS/Fus, which can interact with DNA and RNA, regulates transcription and, in the context of a pathogenic fusion oncoprotein, confers a transcriptional activation domain (Rabbitts et al., 1993) . Besides having a role in preserving genomic integrity (Baechtold et al., 1999; Hicks et al., 2000; Kuroda et al., 2000) , TLS/Fus binds pre-and processed mRNAs, and engages in nucleocytoplasmic RNA transport (Iko et al., 2004; Lerga et al., 2001; Zinszner et al., 1997) . It contains both RNA-binding domains and functions shared with hnRNPs and is known to interact with hnRNPI (Meissner et al., 2003) . hnRNPI binds intronic polypyrimidine tracts, and both hnRNPI and hnRNPK associate in a protein complex (Kim et al., 2000) and interact with Ro ribonucleoprotein-associated Y RNAs (Fabini et al., 2001) ; both factors are implicated in gene transcription and pre-RNA splicing, nuclear export of mature mRNAs, translation and regulation of mRNA stability (Dreyfuss et al., 2002; Reed and Hurt, 2002) . Their interaction and developmental co-regulation with HDGF thus strongly suggests related cellular functions for the latter and represents a novel insight into putative HDGF mechanisms. Recently, cytosolic TLS/Fus, hnRNPs K and I, other RNA-binding proteins, and RNA were found within novel focal adhesionrelated structures called spreading initiation centers (de Hoog et al., 2004) . Our studies do not address the possibility of similar roles for HDGF, although notably, HDGF expression in colon tumors is especially prominent in isolated foci of large, invasive cells (Fig. 5E) .
In summary, HDGF is one of several genes we identify whose peak expression coincides with fetal gut epithelial morphogenesis and in carcinomas of the same developmental origin. HDGF acts to limit epithelial differentiation, which is significant in light of its expression pattern, and associates with a group of nuclear proteins that share biochemical properties and functions in RNA metabolism. Our approach can be extended to identify other oncofetal proteins, which could present safer therapeutic targets, and to better understand molecular mechanisms common to development and cancer.
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